Medical Xpress December 3, 2021

(HealthDay)—Use of genomic sequencing yields an increase in genomic diagnoses across a spectrum of rare diseases, according to a study published in the Nov. 11 issue of the New England Journal of Medicine.

Damian Smedley, Ph.D., from Genomics England in London, and colleagues conducted a involving 4,660 participants from 2,183 families who had 161 disorders covering a broad spectrum of .

The researchers observed variation in diagnostic yields among family structures, with the highest yield in family trios (both parents and a proband) and families with larger pedigrees. Disorders likely to have a monogenic cause had much higher diagnostic yields than those likely to have a complex cause...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine, Survey / Study, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article